Effects of insulin per se on neuroendocrine and metabolic counter-regulatory responses to hypoglycaemia

Clinical Science

Volumn 99, Issue 5, 2000, Pages 351-362

  Galassetti, P ^a   Davis, S N ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Autonomic nervous system; Catecholamines; Counter regulatory responses; Endogenous glucose production; Hypoglycaemia; Insulin

Indexed keywords

CATECHOLAMINE RELEASE; CELL INTERACTION; COGNITION; CONTRAST ENHANCEMENT; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HORMONAL REGULATION; HUMAN; HYPERINSULINEMIA; HYPOGLYCEMIA; INSULIN RESPONSE; LIPOLYSIS; METABOLIC REGULATION; NEUROSECRETORY CELL; PRIORITY JOURNAL; REVIEW; TARGET CELL;

EID: 0033662760     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0990351     Document Type: Review

References (90)

1. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction
2. Effects of physiological hyperinsulinemia on counterregulatory response to prolonged hypoglycemia in normal humans
3. Comparison of glucose counterregulation during short-term and prolonged hypoglycemia in normal humans
4. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation
5. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man
6. Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production and impaired stimulation of glucose utilization
7. Cortisol-induced insulin resistance in man: Impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action
8. Physiological concentrations of growth hormone exert insulin-like antagonistic effects on both hepatic and extrahepatic tissues in man
9. Tissue effects of glucocorticoids
10. Role of gluconeogenesis in sustaining glucose production during hypoglycemia caused by continuous insulin infusion in conscious dogs
11. Contributions of gluconeogenesis and glycogenolysis during glucose counterregulations in normal humans
12. Attenuated glucose recovery from hypoglycemia in the elderly
13. Effects of insulin on the counterregulatory response to equivalent hypoglycemia in normal females
14. Gender influences counterregulatory hormone responses to hypoglycemia
15. Sex differences in the adrenal catecholamine response to hypoglycemia in rats
16. Contribution of cortisol to glucose counterregulation in humans
17. Effects of hyperinsulinemia on the subsequent hormonal response to hypoglycemia in conscious dogs
18. Effect of physiological hyperinsulinemia on counterregulatory hormone response during hypoglycemia in humans
19. Physiological disturbance in hypoglycaemia: Effect on subject awareness
20. Glucose clamp technique: A method for quantifying insulin secretion and resistance
21. Exaggerated epinephrine response to hypoglycemia in normal and insulin dependent diabetic children
22. Hyperinsulinemia suppresses glucose utilization in specific brain regions: In vivo studies using the euglycemic clamp in the rat
23. Insulin infusion in conscious dogs: Effect on systemic and coronary hemodynamics, regional blood flows, and catecholamines
24. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans
25. Effect of insulin and glucose infusions on sympathetic nervous activity in normal man
26. No differential effects of porcine and human insulin on muscle sympathetic nerve activity during euglycemia and hypoglycemia
27. Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity
28. Dynamics of hepatic lactate and glucose balances during prolonged exercise and recovery in the dog
29. The sympathetic response to euglycemic hyperinsulinemia. Evidence from microelectrode nerve recordings in healthy subjects
30. Diet, obesity and hypertension: A hypothesis involving insulin, the sympathetic nervous system and adaptive thermogenesis
31. Hypertension as a disease of carbohydrate and lipoprotein metabolism
32. A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man
33. Suppression of counterregulatory hormone response to hypoglycemia by insulin per se
34. The effect of differing insulin levels on the hormonal and metabolic response to equivalent hypoglycemia in normal humans
35. Exaggerated epinephrine response to hypoglycemia in a physically fit, well-controlled IDDM subject
36. Physiologic hyperinsulinemia enhances counterregulatory hormone responses to hypoglycemia in IDDM
37. Insulin-associated modulation of neuroendocrine counterregulation, hypoglycemia perception, and cerebral function in insulin-dependent diabetes mellitus: Evidence for an intrinsic effect of insulin on the central nervous system
38. Importance of insulin in subjective, cognitive, and hormonal responses to hypoglycemia in patients with IDDM
39. Inhibitory effect of circulating insulin on glucagon secretion during hypoglycemia in Type I diabetic patients
40. Effects of differing insulin levels on response to equivalent hypoglycemia in conscious dogs
41. The role of adrenergic mechanisms in the substrate and hormonal response to insulin induced hypoglycemia in man
42. The effects of insulin on the counterregulatory response to equivalent hypoglycemia in patients with insulin-dependent diabetes mellitus
43. Studies on glucagon secretion using isolated islets of Langerhans of the rat
44. Insulin within islets is a physiologic glucagon release inhibitor
45. Exogenous insulin dose-dependently suppresses glucopenia-induced glucagon secretion from perfused rat pancreas
46. Supraphysiological hyperinsulinemia acutely increases hypothalamic-pituitary-adrenal secretory activity in humans
47. Nycthemeral rhythm in adrenal responsiveness to ACTH
48. Reset of feedback in the adrenocortical system: An apparent shift in sensitivity of adrenocorticotropin to inhibition by corticosterone between morning and evening
49. Insulin resistance of puberty: A defect restricted to peripheral glucose metabolism
50. Differences in circulating gluconeogenic substrates during short-term fasting in men, women, and children
51. Sex differences in insulin action on glucose transport and transporters in human omental adipocytes
52. Sexual dimorphism in insulin sensitivity in adolescents with insulin-dependent diabetes mellitus
53. Influence of sex and obesity on plasma catecholamine response to isometric exercise
54. Sex differences in sympathetic-adrenal medullary reactions induced by different stressors
55. Catecholamine output of males and females over a one-year period
56. Gender differences in counterregulation to hypoglycemia
57. Evidence against a humoral control mechanism in adrenal catecholamine secretion during insulin-induced hypoglycemia
58. Hypoglycemic symptoms and decreased β-adrenergic sensitivity in insulin-dependent diabetic patients
59. Studies on the nature and mode of action of the insulin-sensitive glucoregulator receptor in the central nervous system
60. Cardiovascular response to insulin in the absence of hypoglycemia
61. Evidence for an insulin-sensitive receptor in the central nervous system
62. Vagotomy or atropine blocks hypoglycemic effects of insulin injected into ventromedial hypoglycemic nucleus
63. Insulin-sensitive glucoreceptor 5 in rat preoptic area that regulates FFA mobilization
64. Facilitated transfer of glucose from blood into brain tissue
65. Insulin in the brain
66. The cellular and physiological actions of insulin in the central nervous system
67. Insulin receptors in the central nervous system: Localization, signaling mechanisms and functional aspects
68. Acute hyperinsulinemia and its reversal by vagotomy after lesions of the ventromedial hypothalamus in anesthetized rats
69. Hypothalamic influence on insulin and glucagon release in the rat
70. Hypothalamic stimulation of of growth hormone release
71. Effect of hypothalamic stimulation on plasma glucose, insulin and glucagon levels
72. Effect of hypothalamic stimulation on gluconeogenesis and glycolysis in rat liver
73. Localization of CNS glucoregulatory insulin receptors within the VMH
74. Insulin-binding sites in the rat brain: In vivo localization to the circumventricular organs by quantitative radioautography
75. Human blood-brain barrier insulin receptor
76. Effect of insulin on hexose transport across blood-brain barrier in normoglycemia
77. Effect of hyperinsulinemia on local cerebral insulin binding and glucose utilization in normoglycemic awake rats
78. No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans
79. Regional differences in cerebral blood flow and glucose utilization in diabetic man: The effect of insulin
80. Insulin promotes electrical coupling between cultured sympathetic neurons
81. Effect of sustained physiological hyperinsulinaemia on hypothalamic neuropeptide Y and NPY mRNA levels in the rat
82. STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats
83. Hypothalamic insulin and neuropeptide Y in the offspring of gestational diabetic mother rats
84. Evidence that hypothalamic neuropeptide Y gene expression and NPY levels in the paraventricular nucleus increase before the onset of hyperphagia in experimental diabetes
85. Regulation of glucose metabolism by sympathochromaffin catecholamines
86. The role of the hippocampus in feedback regulation of the hypothalamicpituitary-adrenocortical axis
87. Insulin inhibits pyramidal neurons in hippocampal slices
88. Characterization of insulin-like growth factor I and insulin receptors on cultured bovine adrenal fasciculata cells. Role of these peptides on adrenal cell function
89. Does central obesity reflect 'Cushing's disease of the omentum'?
90. Insulin receptors in the pituitary gland: Morphological evidence for influence on opioid synthesizing cells